Zhang, Ying
Sriramaneni, Raghava N.
Clark, Paul A.
Jagodinsky, Justin C.
Ye, Mingzhou
Jin, Wonjong http://orcid.org/0000-0003-4147-9735
Wang, Yuyuan
Bates, Amber
Kerr, Caroline P. http://orcid.org/0000-0002-2389-9229
Le, Trang
Allawi, Raad
Wang, Xiuxiu
Xie, Ruosen http://orcid.org/0000-0002-0249-0002
Havighurst, Thomas C.
Chakravarty, Ishan
Rakhmilevich, Alexander L.
O’Leary, Kathleen A.
Schuler, Linda A.
Sondel, Paul M.
Kim, Kyungmann
Gong, Shaoqin http://orcid.org/0000-0001-9447-2938
Morris, Zachary S. http://orcid.org/0000-0001-5558-3547
Funding for this research was provided by:
Wisconsin Alumni Research Foundation (UW2020 award)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA014520, DP5OD024576, U01CA233102, P01CA250972)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 19 October 2021
Accepted: 10 August 2022
First Online: 23 August 2022
Competing interests
: S.G., Z.S.M., Y.Z. and R.N.S. are inventors on a filed patent (title: nanoparticles for potentiating effects of radiation therapy on anticancer immunotherapy) managed by the Wisconsin Alumni Research Foundation relating to this work. Z.S.M. is a member of the scientific advisory board for Archeus Technologies and Seneca Therapeutics and received equity options for these companies. Z.S.M. is an inventor on patents or filed patents managed by the Wisconsin Alumni Research Foundation relating to the interaction of targeted radionuclide therapies and immunotherapies, nanoparticles designed to augment the anti-tumor immune response following radiation therapy, and the development of a brachytherapy catheter capable of delivering intra-tumor injectables. The remaining authors declare no competing interests.